These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32711456)

  • 21. The number of primary events per variable affects estimation of the subdistribution hazard competing risks model.
    Austin PC; Allignol A; Fine JP
    J Clin Epidemiol; 2017 Mar; 83():75-84. PubMed ID: 28088594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample size calculation for the combination test under nonproportional hazards.
    Cheng H; He J
    Biom J; 2023 Apr; 65(4):e2100403. PubMed ID: 36789566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restricted mean survival time to estimate an intervention effect in a cluster randomized trial.
    Vilain-Abraham FL; Tavernier E; Dantan E; Desmée S; Caille A
    Stat Methods Med Res; 2023 Oct; 32(10):2016-2032. PubMed ID: 37559486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating sample size in the presence of competing risks - Cause-specific hazard or cumulative incidence approach?
    Tai BC; Chen ZJ; Machin D
    Stat Methods Med Res; 2018 Jan; 27(1):114-125. PubMed ID: 26711503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simulation study comparing the power of nine tests of the treatment effect in randomized controlled trials with a time-to-event outcome.
    Royston P; B Parmar MK
    Trials; 2020 Apr; 21(1):315. PubMed ID: 32252820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Semiparametric competing risks regression under interval censoring using the R package intccr.
    Park J; Bakoyannis G; Yiannoutsos CT
    Comput Methods Programs Biomed; 2019 May; 173():167-176. PubMed ID: 31046992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penalized estimation for proportional hazards models with current status data.
    Lu M; Li CS
    Stat Med; 2017 Dec; 36(30):4893-4907. PubMed ID: 28872695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpoints.
    Cortés Martínez J; Geskus RB; Kim K; Melis GG
    BMC Med Res Methodol; 2021 May; 21(1):99. PubMed ID: 33957892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restricted mean survival time as a summary measure of time-to-event outcome.
    Hasegawa T; Misawa S; Nakagawa S; Tanaka S; Tanase T; Ugai H; Wakana A; Yodo Y; Tsuchiya S; Suganami H;
    Pharm Stat; 2020 Jul; 19(4):436-453. PubMed ID: 32072769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated.
    Royston P; Parmar MK
    BMC Med Res Methodol; 2016 Feb; 16():16. PubMed ID: 26869168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample size formula for proportional hazards modelling of competing risks.
    Latouche A; Porcher R; Chevret S
    Stat Med; 2004 Nov; 23(21):3263-74. PubMed ID: 15490425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous hypothesis testing for multiple competing risks in comparative clinical trials.
    Wen J; Wang MC; Hu C
    Stat Med; 2023 Jun; 42(14):2394-2408. PubMed ID: 37035880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing the ratio of two poisson rates.
    Gu K; Ng HK; Tang ML; Schucany WR
    Biom J; 2008 Apr; 50(2):283-98. PubMed ID: 18311854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficiency of two sample tests via the restricted mean survival time for analyzing event time observations.
    Tian L; Fu H; Ruberg SJ; Uno H; Wei LJ
    Biometrics; 2018 Jun; 74(2):694-702. PubMed ID: 28901017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tests of proportional hazards and proportional odds models for grouped survival data.
    Colosimo EA; Chalita LV; Demétrio CG
    Biometrics; 2000 Dec; 56(4):1233-40. PubMed ID: 11129485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. G-estimation of structural nested restricted mean time lost models to estimate effects of time-varying treatments on a failure time outcome.
    Hagiwara Y; Shinozaki T; Matsuyama Y
    Biometrics; 2020 Sep; 76(3):799-810. PubMed ID: 31829432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studentized permutation method for comparing two restricted mean survival times with small sample from randomized trials.
    Ditzhaus M; Yu M; Xu J
    Stat Med; 2023 Jun; 42(13):2226-2240. PubMed ID: 37070141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing for change-point in the covariate effects based on the Cox regression model.
    Lee CY; Chen X; Lam KF
    Stat Med; 2020 May; 39(10):1473-1488. PubMed ID: 32034921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simulation program for estimating statistical power of Cox's proportional hazards model assuming no specific distribution for the survival time.
    Akazawa K; Nakamura T; Moriguchi S; Shimada M; Nose Y
    Comput Methods Programs Biomed; 1991 Jul; 35(3):203-12. PubMed ID: 1935013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.